QR-Code

Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902

Introduction: Treatment strategies that enhance the efficacy of immunotherapy are desired. Radiotherapy can enhance immunity, but the utility of adding radiotherapy to immunotherapy plus platinum-doubled chemotherapy in patients with metastatic NSCLC has not been explored. Methods: This multicenter,...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Yoko Tsukita, MD, PhD, Rei Umezawa, MD, PhD, Taku Nakagawa, MD, PhD, Akira Anbai, MD, PhD, Tomonori Makiguchi, MD, PhD, Hisashi Tanaka, MD, PhD, Yosuke Horii, MD, PhD, Aya Suzuki, MD, Ryo Morita, MD, PhD, Hitomi Nogawa, MD, Hiroshi Yokouchi, MD, PhD, Nozomu Kimura, MD, PhD, Keiichi Jingu, MD, PhD, Akira Inoue, MD, PhD, Hisatoshi Sugiura, MD, PhD, Eisaku Miyauchi, MD, PhD
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2025-05-01
Schriftenreihe:JTO Clinical and Research Reports
Schlagworte:
NSCLC
Radiotherapy
Abscopal
Pembrolizumab
Chemotherapy
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2666364325000335
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge